Thanks. I'm in pretty large. I was a little apprehensive since the bio sector and Nasdaq was getting hit hard. I think this company has great potential as the go to tests for growing senior healthcare. I think we all know seniors are a big growth part of the economy and heathcare is one of the big stories. I think price to sales can at least double to 5X and maybe expand to 10X with the growth potential, but they will need to execute the business model. That would be over 5 pps. Next qtr is key with the new tests and salesforce training beginning in Feb.